Among CagriSema-treated participants, 73.5% achieved HbA1c of 6.5% or below compared to 15.9% with placebo, demonstrating remarkable dual efficacy for both weight and glycemic endpoints
Your provider will review your symptoms, health history, lifestyle, and wellness goals before recommending a treatment plan
Your body already has the blueprint BPC-157 gives it the signal to build.
Cagrilintide activates amylin receptors (AMY1, AMY2, AMY3) in the brainstem to independently reduce food intake and restore leptin sensitivity
It is one of the most potent antioxidants in the body, playing a critical role in detoxification, immune function, and cellular repair